Cite
HARVARD Citation
Kimura, S. et al. (2020). Treatment-free remission after first-line dasatinib discontinuation in patients with chronic myeloid leukaemia (first-line DADI trial): a single-arm, multicentre, phase 2 trial. Lancet. 7 (3), pp. e218-e225. [Online].